Neurology® Podcast

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan and Dr. Myla Goldman interview Dr. Douglas Goodin about his paper on the use of natalizumab (tysabri) for treatment of multiple sclerosis. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Alexandra Degenhardt interviewing Dr. Neil Lava about practical aspects of natalizumab administration for the Lesson of the Week segment. The participants had nothing to disclose except for Dr. Goodin and Dr. Lava.Dr. Goodin has received honoraria for lectures or as a consultant (directly or indirectly) from Teva Neuroscience, Biogen/Idec, Merck-Serono, Bayer-Schering Healthcare and Berlex Laboratories. Dr. Goodin has received research support from Biogen-Idec, Bayer-Schering and Novartis. Dr. Lava received grants for research in the Sentinel Study.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Neeraj Kumar and Jason Mackey interview Drs. Sharon Nations and Jaya Trivedi about their paper on denture cream: an unusual source of excess zinc. The podcast concludes with Dr. Amy Kahn interviewing Dr. Neeraj Kumar about heavy metals for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Juliana Lockman and Alan Ettinger interview Dr. Ley Sander about his paper on drowning in people with epilepsy. The podcast concludes with Dr. Ted Burns interviewing Dr. Sheldon Horowitz about maintenance of certification for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Drs. Andrew Lees from UK and Regina Katzenschlager from Austria about their trial comparing three initial treatments for Parkinson disease. In this additional segment for this issue, Dr. Overman is introducing a new feature called 'e-pearls' which are brief educational points-pearls-that are often, though not necessarily always, tied to a Neurology article, podcast, or item on the website. The length of each E-Pearl is short and tailored to be read and absorbed within a few minutes. E-pearls are mailed to residents and fellows but in the future we hope to have them available on the website.The podcast concludes with a Clinical Pearl session where Dr. Ryan Overman interviews Dr. S. Nizam Ahmed. Podcast participants had nothing to disclose except for Drs. Lees and Katzenschlager. Dr. Lees received f

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar and Dr. Bud Rowland interview Dr. Don Sanders about his papers describing the results of two recently completed RCT of cellcept in myasthenia gravis. The podcast concludes with Dr. Ted Burns interviewing Dr. Gary Cutter about outcome measures for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Geldmacher interview Drs. Caryn Cramer and Mary Haan from the Department of Epidemiology at the University of Michigan about their paper on use of statins in a cohort study. The podcast concludes with Dr. Julian Bragg interviewing Dr. Susanne May about Cox proportional hazards modeling. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Peter Kang interview Dr. Jerry Mendell, Director, Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital about his paper on gene therapy as a potential treatment for LGMD. The podcast concludes with Dr. Erik Ensrud interviewing Dr. Steve Karceski on the topic of translational research efforts. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. E. Clarke Haley and Brett Kissela interview Dr. Juan F. Arenillas about his paper on metabolic syndrome and resistance to IV thrombolysis. The podcast concludes with Dr. Fadi Nahab interviewing Dr. Tanya Turan for the Lesson of the week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Alessandro Adami and Dr. Gian Paolo Anzola about their paper on increased white matter lesion load in migraine with aura patients. The podcast concludes with Dr. Sean Savitz interviewing Dr. Shunichi Homma for the Lesson of the week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann and Dr. Chris White interview Dr. Thomas Bird about his paper on hereditary axonal neuropathies. The podcast concludes with Dr. Ted Burns interviewing Dr. Peter Dyck about two 1968 landmark publications that led to the commonly-used classification scheme for inherited neuropathies. The participants had nothing to disclose except for Dr. Thomas Bird. Dr. Thomas Bird receives Licensing Fees from Athena Diagnostics Inc and one of the co-authors of the paper, Dr. William Seltzer, is employed as Laboratory Director of Athena Diagnostics.)

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Orly Avitzur interview Dr. James Bernat and Dr. Daniel Larriviere about their paper on threats to physician autonomy. The podcast concludes with Dr. Ryan Overman and Dr. Shanna Patterson interviewing Dr. Bradley Boeve for the first installment of a new series of podcasts called "E-Pearls" which discussed Balint's syndrome. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Beau Bruce interview Dr. Brian G. Weinshenker, Professor of Neurology from the Mayo Clinic about his team's paper on NMO-IgG predicts outcome of recurrent optic neuritis. The podcast concludes with Dr. Ted Burns interviewing Dr. Robert J. Joynt, Section Editor for the Changes People Comments Section with one to be published in this issue. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Kevin Barrett and Dr. Ryan Overman interview Dr. Terry Fife of the Barrow Neurological Institute and University of Arizona and Dr. Gary Gronseth of the University of Kansas about their practice parameter on benign paroxysmal positional vertigo therapies. The podcast concludes with Dr. Marat Reyzelman interviewing Dr. Sharon Hartman Polensek for the Lesson of the week on the topic of positioning maneuver for horizontal canal BPPV. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Erik Ensrud and Dr. Jason Mackey interview Dr. John Steele of Guam Memorial Hospital and Dr. Patrick McGeer of the University of British Columbia about their paper on ALS/PDC syndrome of Guam and the cycad hypothesis. The podcast concludes with reposting of Dr. Farah Mateen interviewing Dr. Donald Mulder on his work in Guam back in the fifties (originally heard as part of the January 8 2008 podcast). Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Carolyn Klein interview Dr. Steve Vernino from the University of Texas, Southwestern Medical Center and Dr. Phillip Low form the Mayo Clinic about their paper on autonomic ganglia. The podcast concludes with Dr. Adam Heller interviewing Dr. Roy Freeman on the topic of the autonomic history for the Lesson of the Week. Podcast participants had nothing to disclose except Dr. Freeman. In the past 12 months, Dr Freeman has received consulting fees from Eli-Lilly, Pfizer, Solace, XtlBio, and Chelsea Pharmaceuticals, and honoraria for speaking from Pfizer and Eli-Lilly.Dr. Freeman has received personal compensation for his editorial activities (Editor) with Autonomic Neuroscience - Basic and Clinical.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Anderson and Dr. Michael K. Hehir interview Dr. Anne Lindblad from the EMMES Corporation and Dr. Robert G. Hart from the University of Texas, Health Science Center about their paper on NINDS-sponsored studies. The podcast concludes with Dr. Brandy Fureman interviewing Dr. Walter Koroshetz on the topic of NIH clinical research collaboration for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns and Dr. Richard Lewis interview Dr. Troels Staehelin Jensen from Aarhus University Hospital in Denmark and Dr. Rolf-Detlef Treede from University of Heidelberg in Germany about their paper on neuropathic pain: redefinition. The podcast concludes with Dr. Bernard Chang interviewing Dr. Gary Franklin for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael K. Sowell and Dr. J. D. Bartleson interview Dr. Tamara Pringsheim from Alberta, Canada about her paper on treatment of menstrually related migraine headache. The podcast concludes with a Clinical Pearl session where Dr. Jason Mackey interviews Dr. Elliot Frohman. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Peter Goadsby and Dr. Stephen Silberstein interview Dr. Tony Ho from Merck & Co., Inc. about his paper on oral CGRP antagonist, MK-0974, in acute treatment of migraine. The podcast concludes with Dr. Myla Goldman interviewing Dr. Bruce Levin for Lesson of the Week. The participants had nothing to disclose except for Dr. Silberstein. His Author Disclosure is as follows: Income for speaking, consulting or serving on an advisory board- GlaxoSmithKline, Allergan, AstraZeneca, Endo, Medtronic, Merck, J&J, Pfizer, Pozen, Valeant Pharmaceuticals International (not in excess of $10,000) & Research Support- Allergan (not in excess of $10,000).

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Leslie Jameieh Cloud and Dr. Cynthia Comella interview Dr. Jacques Montplaisir from the Sleep Studies Center at Sacred Heart Hospital in Montreal about his paper on REM sleep behavior disorder. The podcast concludes with Dr. Daniel O. Claassen interviewing Dr. Bradley F. Boeve for Lesson of the Week. The participants had nothing to disclose.